Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
Journal of the American Geriatrics Society
|
March 10, 2023
Disparities in 30-day readmission rates among Medicare enrollees with dementia
Andrea Gilmore-Bykovskyi, Megan Zuelsdorff, Laura Block, et al.
Cell
|
June 18, 2003
DNA deamination mediates innate immunity to retroviral infection
Reuben S Harris, Kate N Bishop, Ann M Sheehy, et al.
The Journal of Rheumatology
|
August 15, 2022
Age-Stratified 30-day Rehospitalization and Mortality and Predictors of Rehospitalization Among Patients With Systemic Lupus Erythematosus: A Medicare Cohort Study
Maria Schletzbaum, Amy J Kind, Yi Chen, et al.
Mayo Clinic Proceedings
|
December 5, 2020
Thirty-Day Re-observation, Chronic Re-observation, and Neighborhood Disadvantage
Ann M Sheehy, W Ryan Powell, Farah A Kaiksow, et al.
Journal of Molecular Biology
|
December 24, 2017
Locking the Elbow: Improved Antibody Fab Fragments as Chaperones for Structure Determination
Lucas J Bailey, Kimberly M Sheehy, Pawel K Dominik, et al.
Molecular Therapy. Oncology
|
April 10, 2024
Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors
Julia A Nikrad, Robert T Galvin, Mackenzie M Sheehy, et al.
Journal of Virology
|
October 14, 2004
Further investigation of simian immunodeficiency virus Vif function in human cells
Nathan C Gaddis, Ann M Sheehy, K Muneer Ahmad, et al.
Seminars in Arthritis and Rheumatism
|
April 4, 2021
One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days
Christie M Bartels, Ann Chodara, Yi Chen, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Sonya D Zabludoff, Chun Deng, Michael R Grondine, et al.
The Journal of Clinical Investigation
|
February 6, 2019
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth
Shaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
Journal of the American Geriatrics Society
|
March 10, 2023
Disparities in 30-day readmission rates among Medicare enrollees with dementia
Andrea Gilmore-Bykovskyi, Megan Zuelsdorff, Laura Block, et al.
Cell
|
June 18, 2003
DNA deamination mediates innate immunity to retroviral infection
Reuben S Harris, Kate N Bishop, Ann M Sheehy, et al.
The Journal of Rheumatology
|
August 15, 2022
Age-Stratified 30-day Rehospitalization and Mortality and Predictors of Rehospitalization Among Patients With Systemic Lupus Erythematosus: A Medicare Cohort Study
Maria Schletzbaum, Amy J Kind, Yi Chen, et al.
Mayo Clinic Proceedings
|
December 5, 2020
Thirty-Day Re-observation, Chronic Re-observation, and Neighborhood Disadvantage
Ann M Sheehy, W Ryan Powell, Farah A Kaiksow, et al.
Journal of Molecular Biology
|
December 24, 2017
Locking the Elbow: Improved Antibody Fab Fragments as Chaperones for Structure Determination
Lucas J Bailey, Kimberly M Sheehy, Pawel K Dominik, et al.
Molecular Therapy. Oncology
|
April 10, 2024
Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors
Julia A Nikrad, Robert T Galvin, Mackenzie M Sheehy, et al.
Journal of Virology
|
October 14, 2004
Further investigation of simian immunodeficiency virus Vif function in human cells
Nathan C Gaddis, Ann M Sheehy, K Muneer Ahmad, et al.
Seminars in Arthritis and Rheumatism
|
April 4, 2021
One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days
Christie M Bartels, Ann Chodara, Yi Chen, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Sonya D Zabludoff, Chun Deng, Michael R Grondine, et al.
The Journal of Clinical Investigation
|
February 6, 2019
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth
Shaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.
Page
of 13